ClinicalTrials.gov record
Active, not recruiting Phase 1 Interventional

Gemcitabine Hydrochloride, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Metformin Hydrochloride, and a Standardized Dietary Supplement in Treating Patients With Pancreatic Cancer That Cannot be Removed by Surgery

ClinicalTrials.gov ID: NCT02336087

Public ClinicalTrials.gov record NCT02336087. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 6:25 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Pilot Study of Gemcitabine, Abraxane, Metformin and a Standardized Dietary Supplement (DS) in Patients With Unresectable Pancreatic Cancer

Study identification

NCT ID
NCT02336087
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 1
Lead sponsor
City of Hope Medical Center
Other
Enrollment
21 participants

Conditions and interventions

Interventions

  • Gemcitabine Hydrochloride Drug
  • Laboratory Biomarker Analysis Other
  • Metformin Hydrochloride Drug
  • Paclitaxel Albumin-Stabilized Nanoparticle Formulation Drug
  • Quality-of-Life Assessment Other
  • Therapeutic Dietary Intervention Dietary Supplement

Drug · Other · Dietary Supplement

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 13, 2016
Primary completion
Oct 3, 2020
Completion
Dec 8, 2026
Last update posted
Feb 3, 2026

2016 – 2026

United States locations

U.S. sites
4
U.S. states
1
U.S. cities
4
Facility City State ZIP Site status
City of Hope Medical Center Duarte California 91010
City of Hope Rancho Cucamonga Rancho Cucamonga California 91730
City of Hope South Pasadena South Pasadena California 91030
City of Hope West Covina West Covina California 91790

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02336087, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 3, 2026 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02336087 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →